Market Overview

Global Biopsy Devices Market Size, Share & Trends Analysis Report 2012-2020


Global Biopsy Devices Market Size, Share & Trends Analysis Report 2012-2020

PR Newswire

DUBLIN, Aug 31, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, Competitive Landscape, And Segment Forecasts, 2012 - 2020" report has been added to's offering.

The global biopsy devices market size is expected to reach USD 2.3 billion by 2020, progressing at a CAGR of 6.4% during the forecast period.

Growing incidence of cancer, rising geriatric population across the world, and soaring demand for less invasive biopsy procedures are some of the key trends stimulating market growth.

Demand for minimally invasive biopsy procedures is rising at a significant rate in the market. Different types of technologies and products such as, biopsy guiding systems, needle-based biopsy guns, and vacuum assisted devices are anticipated to witness high growth during the forecast period.

North America is likely to command a considerable revenue share in the market throughout the forecast period. On the other hand, Asia Pacific is projected to post a noteworthy CAGR during the same period.

In emerging economies, high price of biopsy devices can hinder the growth of the market. Patients in the countries are generally price sensitive and need more efficient and effective medical technologies and facilities. There are several regulatory changes coming across the world to address unmet needs of patients in these areas.

High unmet patient needs coupled with rapidly improving healthcare infrastructure in emerging countries such as India and China are poised to augment the regional market. Advent of technologically advanced and efficient products such as Vacora and Finesse Ultra Breast Biopsy System by BARD and Celero VAB device by Hologic Inc. is stoking the growth of the market. Besides this, burgeoning popularity of these devices in developed countries such as the U.S., Canada, and Japan are expected to boost the growth of the overall market during the forecast period.

Some of the key players in the biopsy devices market are Inard Inc.; Carefusion Corporation; Devicor Medical Products, Inc; DTR Medical; Hologic Inc.; C.R. Bard Inc. and Cardinal Health Inc. These companies are involved in developing and adding technologically advanced and cost effective instruments to their product portfolio.

Further key findings from the report suggest:

  • Due to rapid technological advancements and high efficiency, biopsy guidance systems are anticipated to register sharp rise in their demand over the forecast period
  • Surging demand for less invasive surgeries and disposable biopsy devices is one of the primary growth stimulants for the market
  • Technologies such as vacuum assisted biopsy devices are able to facilitate easy removal of large tissue samples. Upsurge in their demand will influence the overall market positively
  • The North America market was at the forefront of the market. The region is driven by various factors such as better infrastructure, patient awareness, and good healthcare facilities
  • Asia Pacific is estimated to emerge as the fastest growing region in the global arena.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Biopsy Devices Industry Outlook
2.1 Market Segmentation
2.2 Market size and growth prospects
2.3 Biopsy devices - Market dynamics
2.3.1 Market Driver Analysis Growing prevalence of cancer Growing global geriatric population base Increasing demand for minimally invasive medical procedures Growing cancer related spending triggering the need for effective diagnostic procedures
2.3.2 Market Restraint Analysis High product prices
2.4 Key Opportunities Prioritized
2.5 Industry Analysis - Porter's
2.6 Biopsy devices - PESTEL Analysis
2.7 Company market share analysis

Chapter 3 Biopsy Devices Product Outlook
3.1 Biopsy devices market share by product, 2013 & 2020
3.2 Needle based biopsy guns
3.2.1 Needle based biopsy guns' market, 2012 - 2020 (USD Million)
3.2.2 Vacuum-assisted biopsy (VAB) devices
3.2.3 Fine needle aspiration biopsy (FNAB) devices
3.2.4 Core needle biopsy (CNB) devices
3.3 Biopsy guidance systems
3.3.2 Manual guidance system
3.3.3 Robotic guidance system
3.4 Biopsy needles
3.4.1 Biopsy needles market, 2012 - 2020 (USD Million)
3.4.2 Disposable biopsy needles
3.4.3 Reusable biopsy needles
3.5 Biopsy forceps
3.5.2 Cold/General biopsy forceps
3.5.3 Hot biopsy forceps
3.6 Other biopsy devices
3.6.1 Other biopsy devices Market, 2012 - 2020 (USD Million)
3.6.2 Brushes
3.6.3 Curettes
3.6.4 Punches

Chapter 4 Biopsy Devices Regional Outlook

Chapter 5 Competitive Landscape

  • Angiotech (Surgical Specialties Corporation)
  • Cardinal Health Inc.
  • Carefusion Corporation
  • C.R. Bard Inc.
  • Devicor Medical Products Inc.
  • DTR Medical
  • Hologic, Inc
  • INRAD, Inc

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Cision View original content with multimedia:

SOURCE Research and Markets

View Comments and Join the Discussion!